Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03410784
Title Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer (MITO28MaNGOov4)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute, Naples
Indications

fallopian tube cancer

ovary epithelial cancer

peritoneal carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.